Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Precision Oncology Market Revenue Outlook: What CAGR Is Expected Through 2030?
The precision oncology market has experienced significant expansion in recent years. Projected to rise from $106.21 billion in 2025 to $117.67 billion in 2026, this growth reflects a compound annual growth rate (CAGR) of 10.8%. Historically, this upward trend has been driven by factors such as the restricted access to genomic sequencing tools, a continued dependence on traditional chemotherapy, a worldwide increase in cancer incidence, the early integration of immunotherapy, and advancing investigations into molecular oncology.
Over the coming years, the precision oncology sector is anticipated to expand swiftly, reaching a projected valuation of $175.38 billion by 2030, driven by a compound annual growth rate of 10.5%. This upward trajectory in the forecast period is fueled by the advancement of next-generation sequencing platforms, the growing incorporation of bioinformatics and artificial intelligence into oncology practices, the rising use of liquid biopsy and molecular imaging techniques, the broadening spectrum of personalized therapeutic choices, and an uptick in research partnerships between hospitals and pharmaceutical firms. Key developments shaping the landscape include the broadening of cancer therapies tailored through molecular profiling, a greater reliance on liquid biopsy and minimally invasive diagnostic tools, an upswing in biomarker-driven testing for customized treatment strategies, the increasing fusion of immunotherapy with genomic sequencing, and a heightened emphasis on tackling rare and challenging cancer types.
Download A Free Sample Report For Comprehensive Market Insights:
Precision Oncology Market Growth Drivers: What Factors Are Accelerating Expansion?
The growing recognition and movement toward individualized treatment approaches are anticipated to fuel expansion within the precision oncology sector in the coming period. Customized therapies are designed based on a patient’s genetic profile, biomarkers, and specific disease features in order to maximize therapeutic outcomes while minimizing adverse effects. Their adoption is accelerating largely because of progress in genomic technologies, which now allow for precise identification of mutations responsible for disease progression, enabling more accurate and targeted interventions. By leveraging genomic and molecular profiling, precision oncology plays a key role in advancing these personalized treatments, tailoring cancer care according to the unique genetic characteristics of each patient’s tumor. As an example, in February 2023, the UK government’s Health and Social Care Secretary, as reported by GOV.UK, entered into a memorandum of understanding with BioNTech SE aimed at advancing cancer vaccine research in England, with the goal of making 10,000 personalized therapy doses available to British patients by 2030. Consequently, the increasing focus on and transition toward custom-tailored therapies is driving forward the growth of the precision oncology market.
Precision Oncology Market Segment Performance And Strategic Opportunities
The precision oncology market covered in this report is segmented –
1) By Type: Genomic Sequencing, Immunotherapy
2) By Test Type: Genetic Tests, Biomarker-Based Tests, Therapeutics
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers
4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy
5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers
Subsegments:
1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing
2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy
Precision Oncology Market Trends: What Is Shaping Future Industry Growth?
Leading players within the precision oncology sector are actively pursuing novel strategies, including the implementation of molecular tumor boards, to facilitate individualized treatment choices that merge genomic data with clinical considerations. A molecular tumor board is defined as a specialized panel of professionals tasked with reviewing and deciphering intricate genomic and molecular testing results, thereby guiding targeted cancer treatments that address the distinct tumor traits of each patient. For example, in December 2024, Aster DM Healthcare Ltd., a healthcare organization headquartered in the UAE, launched a precision oncology clinic as part of three personalized cancer care programs aimed at revolutionizing therapy through data- and genomics-based methods. This facility provides tailored cancer treatments derived from the genetic profile of an individual’s tumor, allowing for more accurate and effective interventions while lowering adverse effects. The strategy boosts therapeutic results, lessens toxicity, and elevates quality of life by matching therapies with the distinct molecular characteristics of a patient’s cancer.
Precision Oncology Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.
Access The Complete Precision Oncology Market Report:
Precision Oncology Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the precision oncology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model